Tagged: GENZ

Cephalon Being Acquired By Valeant Pharma

United States based Cephalon Inc. (NASDAQ:CEPH) has been offered a $5.7 billion hostile bid offer by Canadian based Valeant Pharmaceuticals International Inc. (NYSE:VRX) The Canadian based drug maker who manufactures dermatology and neurology based...